Pediatric lymphoma of bone is a type of non-Hodgkin lymphoma, a cancer in the lymphatic system. The lymphatic system is part of the immune system, and works to fight disease and infections. Lymphoma of bone is considered to be a widespread disease, because usually multiple sites in the body are involved as primary sites. In some children however, the tumor may arise in the bone only.
Characteristics of pediatric lymphoma
Lymphoma of bone tends to spread to the other organs and tissues in the body.
It’s thought to be caused by genetics and/or exposure to viral infections, radiation, or chemotherapy.
It’s more common in Caucasian boys.
Treatments may involve a combination of therapies including surgery, radiation, chemotherapy and/or stem cell transplants.
How Dana-Farber/Boston Children’s Cancer and Blood Disorders Center approaches pediatric lymphoma of bone
Patients with lymphoma of the bone are treated through Dana-Farber/Boston Children's Cancer and Blood Disorders Center, an integrated pediatric hematology and oncology partnership between Dana-Farber Cancer Institute and Boston Children’s Hospital. We utilize the expertise of both Boston Children’s Hospital and Dana-Farber Cancer Institute and all members of our physician team — from Oncology, Radiation Oncology, Surgery, Interventional and Diagnostic Radiology and Hematopathology — have expertise in treating pediatric lymphomas. Your child will also have access to unique Phase I clinical trials, from our own childhood cancer research investigators, and from the Children’s Oncology Group.